What Is Driving IperionX (ASX:IPX) Shares Higher Today?

Sonal Goyal

10 November 2026 02:41 PM AEDT

What Is Driving IperionX (ASX:IPX) Shares Higher Today?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

IperionX shares were up 10.93% at $2.39 during the 10 November 2026 trading session.
The company produced 8.7 tons of HAMR titanium powder in the September quarter, compared with 1.4 tons in the June quarter.
A second sintering furnace is scheduled for commissioning in the December 2026 quarter.

IperionX Limited (ASX:IPX) shares were trading higher during the 10 November 2026 session, up 10.93% at $2.39 at midday AEDT. The S&P/ASX 200 was also higher in the same session, up 1.13% at 9,131.90 around 12:30 pm AEDT. IperionX is a titanium metal and powder producer listed on Nasdaq and the ASX, with Manufacturing operations in Virginia. Its most recent update was its September 2026 quarterly report, released on 29 October 2026, which covered titanium powder production, sintering capacity and fastener manufacturing.

About the company

IperionX produces titanium powder using its proprietary HAMR process and manufactures titanium fasteners, billet and bar products for defence and commercial applications. The company describes its operations as being moved toward in-house fastener production in Virginia.

Quarterly report released on 29 October 2026

IperionX produced 8.7 tons of HAMR titanium powder during the quarter, up from 1.4 tons in the June quarter, and closed the period with 19 tons of finished titanium powder inventory and 207 tons of titanium scrap feedstock. The company said its furnace capacity was validated above the 200 tonnes a year annualised run-rate target, and that powder met or exceeded Grade 5 titanium quality specifications.

The company also optimised tooling and pressing parameters for a range of titanium fastener geometries for defence and commercial applications. It said fastener production now runs largely in-house in Virginia, and that it has expanded finish machining and thread-rolling capability.

Sintering capacity and Downstream programs

The first of two additional sintering furnaces has been commissioned, and the second is installed and scheduled for commissioning in the December quarter. IperionX said this removes a key downstream constraint and should increase finished titanium product output. It also dedicated a wet-bag cold isostatic press to large titanium billet and bar production, which it described as a domestic alternative to conventional mill products.

Sector Context

Titanium Demand is linked to aerospace, defence and industrial manufacturing, where US Supply chain security is a growing focus. The company's update points to domestic production and fastener supply as its near-term commercial focus.

Risks to Consider

Commercial programs are still being executed, and customer qualification is ongoing.
Output rose sharply from a low base, and sustained run-rate production over several quarters has yet to be shown.
Sintering and downstream capacity depend on the commissioning of the second furnace in the December quarter.

What to Watch Ahead

Commissioning of the second Elnik sintering furnace in the December 2026 quarter.
Progress on near-term commercial programs and customer qualification.
Finished titanium product output and inventory levels in the next quarterly report.

Final Word

IperionX's September quarter update covers higher powder output, expanded fastener capability and new sintering capacity. The coming quarters will show how these operational gains translate into commercial sales.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.